Drug
Estrofem
Estrofem is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
unknownphase_4
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders
NCT04797338
completed
The Temporo-spatial Dynamics of Genital Tract Microbiota
NCT03363828
unknownnot_applicable
Endometrial Preparation in Frozen Embryo Transfer Cycles
NCT03540979
Clinical Trials (3)
Showing 3 of 3 trials
NCT04797338Phase 4
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders
NCT03363828
The Temporo-spatial Dynamics of Genital Tract Microbiota
NCT03540979Not Applicable
Endometrial Preparation in Frozen Embryo Transfer Cycles
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3